Both brands dominate the dog joint supplement aisle — one through decades of veterinary recommendations and published clinical trials, the other through a modern formula leaning on green-lipped mussel and social media reach. They use meaningfully different ingredients and target different types of joint problems. Which one your dog actually needs depends on more than brand loyalty.
The questions owners actually type when their dog starts limping or slowing down on walks. Answered plainly, without the marketing spin from either brand.
Cosequin, made by Nutramax Laboratories, carries the distinction of being the most-recommended retail joint supplement by small animal veterinarians in the U.S. based on independent surveys — a position it has held for decades. This isn’t just marketing: Cosequin’s proprietary glucosamine form (FCHG49®) and chondroitin form (TRH122®) have been validated in published, peer-reviewed, controlled veterinary studies. PetLab Co. is a newer DTC (direct-to-consumer) brand without the same depth of independent veterinary clinical trial data, though its primary ingredient — green-lipped mussel — has a legitimate and growing body of supporting research. If your vet recommends a specific supplement without naming a brand, Cosequin is likely what they have in mind. If they mention green-lipped mussel or a marine-based omega-3 formula, PetLab’s approach fits that recommendation better.
It matters, and PetLab’s answer to it is worth understanding. Chondroitin sulfate is a large-molecule glycosaminoglycan that helps inhibit cartilage-degrading enzymes and retain water within joint cartilage. PetLab’s formula uses green-lipped mussel as its primary source of glycosaminoglycans — mussel meat naturally contains chondroitin precursors alongside omega-3 fatty acids and other bioactive lipids. Whether that natural matrix delivers equivalent benefit to standardized pharmaceutical-grade chondroitin sulfate is not settled by current research. The honest answer: green-lipped mussel and chondroitin sulfate are not interchangeable. Green-lipped mussel has its own clinical evidence and meaningful anti-inflammatory effects. Isolated chondroitin sulfate has different evidence and works through a somewhat different mechanism. A dog with severe osteoarthritis may benefit from having both — which neither formula alone provides completely.
This is worth addressing carefully — a frequently misquoted claim. A 2023 double-blind, placebo-controlled trial published in Frontiers in Veterinary Science found that a green-lipped mussel and krill oil extract significantly improved mobility in dogs with hip osteoarthritis, while glucosamine-chondroitin performed similarly to placebo over 6 weeks. A systematic review published around the same time concluded that the evidence for glucosamine-chondroitin in managing osteoarthritis pain in dogs is weaker than for omega-3 fatty acids and some other compounds. However, an older multi-center RCT did show significant improvement with glucosamine-chondroitin by day 70 — slower onset than NSAIDs but statistically meaningful. The current picture: glucosamine-chondroitin’s evidence is mixed and dose-dependent; omega-3-rich formulas like green-lipped mussel have emerging stronger support for pain and mobility. Neither replaces veterinary diagnosis and, where needed, prescription pain management.
The cost difference is real and significant. Cosequin Maximum Strength Plus MSM, bought in a 250-tablet bottle at Costco, breaks down to roughly $0.15 per tablet — for a 60-pound dog at 2 tablets per day during the loading phase, that’s about $9 per month during maintenance. PetLab’s Joint Care Chews run approximately $25–$37 per month on subscription. For a similar-weight dog, you’re paying 2–4× more per month for PetLab. What you’re getting for that premium: green-lipped mussel (meaningful clinical support), turmeric extract (some evidence but questionable absorption in this form), and anchovy-derived omega-3s — none of which Cosequin contains. If green-lipped mussel and omega-3 support matter to you, PetLab’s premium is partially justified by ingredient differences. If your goal is standard glucosamine-chondroitin-MSM at the lowest cost, Cosequin at Costco is hard to beat.
Not necessarily — especially if you’re seeing improvement. For a senior dog already responding to Cosequin, the better move is often to add a separate omega-3 supplement (fish oil or green-lipped mussel powder) rather than switch entirely. This gives the dog the structural support of proven glucosamine-chondroitin-MSM plus the anti-inflammatory benefits of marine omega-3s — a combination neither brand alone provides completely. If Cosequin hasn’t produced noticeable improvement after 8–12 weeks at the recommended loading dose, that’s a reasonable point to discuss alternatives with your vet. Switching from a working protocol carries its own risk: joint supplements take weeks to reach therapeutic levels, and a changeover period can mean a temporary gap in support.
Pet supplements are regulated as animal feed under FDA oversight — meaning companies do not need pre-market safety or efficacy approval, only post-market accountability when problems are reported. In April 2025, the FDA issued a wave of warning letters to pet supplement companies for making unapproved drug claims. The primary quality signal currently available to consumers is NASC (National Animal Supplement Council) certification — a voluntary program in which member companies undergo third-party facility audits every two years and maintain adverse event reporting systems. Both PetLab Co. and Nutramax (Cosequin’s maker) are NASC members. Cosequin adds an additional layer by conducting lot-specific potency testing — the brand’s claim that it “meets label claim” means each batch is verified to contain what the label states at the quantities listed. Always verify NASC membership at nasc.cc before purchasing any pet supplement.
For dogs that resist tablets, yes — compliance is the foundation of any supplement working at all. A 90-day course of a “better” supplement taken 40% of the time is less effective than a “good enough” supplement taken every day. PetLab’s soft chews in pork flavor are widely reported as highly palatable — most dogs take them willingly as a treat. Cosequin also offers a soft chew version (in addition to standard tablets) at a somewhat higher cost per serving than the tablet form. If tablet compliance is a real problem in your household, check whether Cosequin’s soft chew version fits your budget before switching brands entirely — you may be able to keep Cosequin’s ingredient profile while solving the palatability problem. The soft chew version costs more per day than tablets but still comes in below PetLab’s subscription pricing at most retail outlets.
Every meaningful difference between the two formulas, laid out so you can see where they diverge and where they actually overlap.
| Category | 🌿 PetLab Co. | 🔬 Cosequin (DS + MSM) |
|---|---|---|
| Primary glucosamine form | Glucosamine HCl | FCHG49® Glucosamine HCl (patented, clinically validated) |
| Chondroitin | None (relies on GLM as natural source) | TRH122® Sodium Chondroitin Sulfate 300 mg (patented, standardized) |
| MSM (methylsulfonylmethane) | Not included | 250 mg (in MSM variant) |
| Green-lipped mussel | MMP-50™ NZ whole mussel extract (key active) | Not included |
| Omega-3 fatty acids | From GLM + anchovy oil | In Omega-3 soft chew variant only; not in standard DS |
| Turmeric / curcumin | Curcugen® (patented extract, 25 mg) | Not included |
| Calcium fructoborate | Included (boron joint support) | Not included |
| Form factor | Soft chew (pork or salmon flavor) | Tablet or soft chew (multiple variants) |
| Independent clinical trials on product | GLM ingredient has trials; PetLab product itself not independently trialed | Published peer-reviewed RCTs on Cosequin directly |
| NASC certified | Yes — NASC member | Yes — NASC member |
| Made in USA | Yes — manufactured in U.S., globally sourced ingredients | Yes — manufactured in U.S., globally sourced ingredients |
| Vet recommendation rate | Growing; not yet in top independent surveys | #1 vet-recommended retail joint supplement — 25+ years |
| Approximate monthly cost | ~$25–$37/mo (subscription) | ~$9–$18/mo (tablet, size-dependent) |
| Where to buy | thepetlabco.com · Chewy · Amazon · Walmart | Costco · Walmart · Chewy · Amazon · Petco · PetSmart |
Chondroitin: via GLM
Green-lipped mussel ✓
MSM: ✗ none
Turmeric (Curcugen®) ✓
Omega-3 (GLM + anchovy) ✓
Chondroitin (TRH122®) ✓
GLM: ✗ none
MSM 250 mg ✓
Turmeric: ✗ none
Omega-3: in separate variant
PetLab product itself: no independent trials
thepetlabco.com · Chewy · Amazon
Costco · Walmart · Chewy · Amazon
Made in USA
3rd-party testing per brand
Made in USA
Lot-specific label claim testing
Labels are only useful if you understand what each ingredient does and whether the quantity delivered makes a meaningful difference. Here’s an honest look at both formulas, ingredient by ingredient.
Glucosamine is an amino sugar found naturally in joint cartilage, involved in maintaining the synovial fluid that cushions movement. PetLab uses the hydrochloride (HCl) form — the same form as Cosequin’s patented FCHG49®, though PetLab’s version is not independently validated through published clinical trials under this brand. Glucosamine has been used in joint supplements for decades with a mixed-but-real evidence base: older studies showed meaningful improvement by day 70 in dogs with osteoarthritis; more recent placebo-controlled trials have found weaker effects, particularly for pain management compared to anti-inflammatory drugs or GLM-based formulas. Works best as a structural support ingredient rather than a pain-relief ingredient.
This is PetLab’s primary differentiating ingredient and its strongest clinical card. Green-lipped mussel from New Zealand is one of a small number of natural ingredients with published, placebo-controlled clinical trial evidence for canine joint comfort. A 2024 double-blind trial in Frontiers in Veterinary Science found that a GLM and krill oil extract produced results statistically equivalent to meloxicam (an NSAID) at 6 weeks — significantly outperforming placebo and a competing supplement. GLM works through multiple mechanisms: its unique omega-3 fatty acid ETA inhibits both COX-2 and LOX inflammatory pathways simultaneously, and it naturally contains glycosaminoglycans including chondroitin precursors, vitamins, and minerals. Quality varies significantly between GLM products — the fat content and processing method determine potency. PetLab’s MMP-50™ designation indicates a whole mussel extract rather than a processed isolate, which most researchers consider preferable.
PetLab uses a patented turmeric extract (Curcugen®, 25 mg per chew) that the manufacturer claims has improved bioavailability compared to standard curcumin powder. Curcumin — the active compound in turmeric — has anti-inflammatory properties, but standard curcumin has notoriously poor absorption in dogs without a bioavailability enhancer like piperine. Whether Curcugen® overcomes this well enough at 25 mg to deliver meaningful benefit is not established by independent canine studies. Think of this as a supporting ingredient, not a primary driver. If curcumin anti-inflammatory support is a priority, your vet may suggest Boswellia serrata as an alternative with better absorption data in dogs.
PetLab delivers omega-3s from two sources: the green-lipped mussel itself and a separate anchovy-derived oil. Marine omega-3 fatty acids (EPA and DHA) have some of the strongest evidence among all joint supplement ingredients for dogs — a systematic review and meta-analysis found measurable, meaningful benefit for omega-3-enriched diets in canine osteoarthritis. Anchovy is a lower-mercury, lower-trophic-level source than salmon, which is a legitimate quality advantage. The combined delivery from GLM plus anchovy oil gives broader fatty acid coverage than a single source. This omega-3 component is genuinely evidence-backed and represents a real advantage over Cosequin’s standard DS formula, which includes no meaningful omega-3 content.
Cosequin uses a patented glucosamine form (FCHG49®) at 600 mg per tablet — a dose actually validated in peer-reviewed clinical trials. This matters more than it sounds: most commercial glucosamine supplements contain 300–500 mg and describe it as “joint support,” while veterinary researchers generally consider 1,200–1,500 mg per day the minimum therapeutic target for a 60-pound dog. With Cosequin, a 60-pound dog receives 1,200 mg glucosamine during the loading phase (2 tablets daily), falling within the range associated with measurable clinical improvement. The FCHG49® designation specifically means this form has been evaluated in published studies rather than borrowed from bulk ingredient suppliers without testing. Dose matters as much as ingredient choice in glucosamine supplementation.
Chondroitin sulfate is a large-molecule glycosaminoglycan that works by inhibiting cartilage-degrading enzymes and promoting water retention in cartilage tissue, keeping it hydrated and resilient under load. Cosequin uses a pharmaceutical-grade form (TRH122®) that has been specifically evaluated for bioavailability and purity. The challenge with chondroitin at any source: it’s a large molecule with variable absorption, and extraction quality differs dramatically across suppliers. Bovine-sourced chondroitin consistently outperforms shark-derived sources in bioavailability tests. Cosequin’s TRH122® designation ensures purity standards that generic chondroitin products don’t guarantee. The combination of standardized glucosamine and pharmaceutical-grade chondroitin together is where Cosequin’s clinical evidence lives — the two work synergistically in ways neither does alone.
MSM provides organic sulfur to support connective tissue and is generally included in joint supplements for its anti-inflammatory contribution and its role in collagen synthesis. The evidence base for MSM alone in dogs is thinner than for glucosamine or chondroitin, but it’s consistently used alongside them as a synergistic third ingredient. At 250 mg per tablet, MSM is within a reasonable daily range for medium to large dogs. The DS+MSM variant is the most commonly purchased Cosequin formulation and the one most frequently referenced when veterinarians say “Cosequin.” MSM is absent from PetLab’s Joint Care Chews — another ingredient gap to consider for dogs with advanced joint disease.
Cosequin’s standard DS and DS+MSM formulas do not include green-lipped mussel, turmeric, or meaningful omega-3 fatty acids — all of which have evidence supporting them for canine joint health. Cosequin does offer an Omega-3 soft chew variant that adds DHA/EPA, but the original tablet formula is purely glucosamine-chondroitin-MSM. This is both a strength and a limitation. The strength: decades of veterinary trust built on a consistent, well-understood formula. The limitation: newer research suggests that omega-3 fatty acids and GLM may offer meaningful anti-inflammatory benefits that glucosamine-chondroitin alone doesn’t cover. For a comprehensive protocol, some vets now recommend combining Cosequin with a separate high-quality fish oil supplement — which can bring the total cost closer to PetLab’s monthly pricing while covering more of the evidence base.
Joint supplement marketing is relentless and often distorts the underlying science. Here’s what the actual published research supports — and where the evidence is genuinely uncertain.
Glucosamine and chondroitin have been used in veterinary practice for over 25 years and carry a multi-center randomized controlled trial showing statistically significant improvement in dogs with hip or elbow osteoarthritis by day 70 — slower onset than NSAIDs like carprofen, but real. A 2023 double-blind, placebo-controlled trial published in Frontiers in Veterinary Science found a different result: glucosamine-chondroitin performed similarly to placebo over 6 weeks, while a green-lipped mussel and krill oil compound showed results comparable to carprofen at 4 and 6 weeks. A systematic review around the same period concluded that the evidence for glucosamine-chondroitin in managing osteoarthritis pain is weaker than for omega-3-based approaches. The current scientific picture: glucosamine-chondroitin may support cartilage structure and provide modest benefit, but their role as pain-management agents in dogs with OA has come under legitimate scrutiny. Dose, form, and the specific dog’s disease stage all affect outcomes. The verdict isn’t that they’re useless — it’s that they’ve been oversold as primary pain-relief tools, a role better filled by omega-3s, GLM, or where needed, veterinary-prescribed NSAIDs.
Green-lipped mussel has accumulated over 150 published studies across 40+ years. In a 2024 double-blind, placebo-controlled trial involving 101 dogs with hip osteoarthritis (published in Frontiers in Veterinary Science), a GLM + krill oil extract achieved results statistically equivalent to meloxicam — a commonly prescribed NSAID — at 6 weeks, significantly outperforming both a competing supplement and placebo. An earlier Finnish randomized controlled trial found significant improvement in dogs fed a GLM-enriched diet, though GLM was not as effective as carprofen at the same time points. A comprehensive review of over 150 GLM publications confirmed consistent alleviation of arthritis symptoms and chronic orthopedic pain in dogs. GLM works through a genuinely different mechanism than glucosamine-chondroitin: its unique omega-3 fatty acid ETA (eicosatetraenoic acid) inhibits both COX-2 and LOX inflammatory pathways simultaneously, which standard fish oil does not do. This dual-pathway anti-inflammatory action is one reason GLM outperforms standard glucosamine-chondroitin in recent head-to-head trials.
Of all non-pharmaceutical interventions for canine osteoarthritis, omega-3 fatty acids from marine sources have the most consistent evidentiary support. A systematic review and meta-analysis of nutraceuticals for canine and feline OA found evidence of efficacy for omega-3-enriched diets and omega-3 supplements — and a “very marked non-effect” for glucosamine-chondroitin. A Canadian study from the Université de Montréal showed that dogs fed a GLM-enriched diet for 60 days demonstrated measurable improvements in peak vertical force (the gold standard for assessing lameness) alongside significantly increased plasma omega-3 concentrations. The clinical takeaway: if you can only afford one ingredient-class change in your dog’s joint protocol, marine omega-3s likely have the most consistent scientific support — whether delivered through green-lipped mussel (PetLab’s approach), a dedicated fish oil supplement, or an omega-3 enriched prescription diet. This is also the area where PetLab’s formula has a genuine ingredient advantage over Cosequin’s standard tablet.
The monthly cost of a joint supplement changes significantly based on your dog’s weight and which format you choose. Here’s what each brand actually costs across common size categories.
PetLab sells primarily through its own website at thepetlabco.com, Chewy, Amazon, and Walmart. The subscription model offers roughly 25% savings over one-time purchase pricing. A 30-count bag — one month’s supply for all dog sizes at one chew per day — runs approximately $25–$37 per month on subscription. One chew per day regardless of weight is the standard dosing. This makes PetLab’s cost predictable across dog sizes, which is an advantage for large breed owners: a 90-pound dog costs the same per month as a 15-pound dog. The subscription auto-renews and first-order discounts do not apply to renewals — confirm the renewal price before subscribing. Contact: thepetlabco.com or customer service at the number listed on their website.
Cosequin is available at Costco, Walmart, Chewy, Amazon, Petco, and PetSmart in a wider range of count sizes than PetLab. The 250-count bottle at Costco consistently delivers the lowest per-tablet cost — around $0.15–$0.20 per tablet. Dosing is weight-based during the 4–6 week loading phase, then reduced for maintenance. A 30-pound dog uses 1 tablet per day maintenance (~$4.50–$6/month). A 60-pound dog uses 1–2 tablets per day maintenance (~$4.50–$9/month). A 90-pound dog uses 1–2 tablets per day maintenance (~$4.50–$9/month). Large breed owners save significantly with Cosequin at Costco versus PetLab’s flat subscription pricing — particularly if the dog is at the maintenance phase (lower tablet count). Contact Nutramax directly at nutramax.com or cosequin.com.
Using a 50-pound dog as a representative example: Cosequin DS+MSM during the 4–6 week loading phase (2 tablets/day at ~$0.18/tablet) costs roughly $10–$11 per month. At maintenance (1 tablet/day), that drops to approximately $5–$6 per month. PetLab’s Joint Care Chews for the same dog: 1 chew per day on subscription at approximately $27–$33/month. Over a year at maintenance: Cosequin ≈ $60–$72. PetLab on subscription ≈ $300–$400. The annual cost difference is $230–$330 for a single mid-size dog. Whether PetLab’s ingredient advantages (GLM, omega-3s, turmeric) justify that premium depends on whether you believe those ingredients serve your specific dog’s needs — and whether adding a $10–$15/month fish oil supplement to Cosequin would close most of that ingredient gap for significantly less money than switching entirely.
Pet supplements do not go through the same pre-market approval process as prescription medications. Understanding what quality signals actually mean — and how to spot them — matters before you spend money on either brand.
The FDA regulates pet supplements as animal feed under the Federal Food, Drug, and Cosmetic Act — not as drugs. This means no mandatory pre-market safety review, no efficacy requirement, and no standardized potency testing before a product hits shelves. In April 2025, the FDA issued a wave of warning letters to pet supplement companies for making unapproved drug claims — language suggesting a supplement can treat, cure, or prevent a disease, which is not permitted for non-pharmaceutical products. This regulatory environment means label claims vary enormously in scientific backing, and a product can legally contain “glucosamine” without specifying the form, dose validation, or whether the stated quantity is actually in the product. For both PetLab and Cosequin, their NASC membership is the primary quality signal — but it’s the floor, not the ceiling, of what quality-conscious consumers should check.
The National Animal Supplement Council (NASC) Quality Seal is currently the closest thing to independent quality assurance available in the pet supplement space. NASC member companies must undergo third-party facility audits every two years, maintain an adverse event reporting system, comply with NASC labeling standards developed in collaboration with the FDA, and meet good manufacturing practices (GMPs). Both PetLab Co. and Nutramax (Cosequin’s maker) are NASC members. Verify membership at nasc.cc before purchasing any pet supplement — NASC publishes its current member list publicly. NASC membership doesn’t guarantee clinical efficacy, but it does meaningfully reduce the risk of contaminated, counterfeit, or intentionally mislabeled products.
Nutramax’s long-standing quality claim for Cosequin is that each production lot undergoes potency testing to verify it “meets label claim” — meaning what’s on the label is what’s in the bottle, at the quantities stated. This lot-by-lot verification is not universal in the pet supplement industry and represents a meaningful quality advantage over brands that rely solely on supplier certificates of analysis. PetLab Co. states its products are manufactured in the U.S. under quality control standards and undergo third-party testing, though the specific protocol for label claim verification is less clearly documented in publicly available materials. If your dog’s treatment depends on a specific, consistent dose of an active ingredient — particularly at higher price points — Cosequin’s documented lot testing is a genuine quality differentiator. Ask any brand for a certificate of analysis for the specific lot you purchased; reputable manufacturers will provide it.
Start with your veterinarian. For a dog already showing pain — reluctance to rise, limping, behavioral changes — a joint supplement alone is rarely sufficient as a sole intervention for moderate to severe OA. Prescription NSAIDs or other pain management have faster onset and stronger evidence for pain control than any supplement. That said, supplements play a supporting role in a comprehensive protocol. For documented OA, Cosequin’s 25-year track record in veterinary practice, published peer-reviewed clinical data on the Cosequin product itself, and the combination of glucosamine-chondroitin-MSM make it the more defensible choice as a supplement partner to prescription therapy. Consider asking your vet about adding a high-quality fish oil supplement alongside Cosequin — this combination covers more of the evidence base than either supplement alone and remains less expensive than switching to PetLab entirely.
A veterinary exam first establishes the cause — not all stiffness is osteoarthritis, and not all osteoarthritis presents the same way or at the same stage. Once you understand what you’re dealing with, the supplement decision is clearer. For early, mild joint stiffness in a dog without a severe OA diagnosis, PetLab’s green-lipped mussel formula with omega-3s has evidence supporting it, the soft chew format is easy to give, and the multi-ingredient approach (GLM, glucosamine, turmeric, omega-3) addresses more of the relevant biological targets than Cosequin’s glucosamine-chondroitin alone. The tradeoff: PetLab costs more and hasn’t had the Cosequin product itself tested in published RCTs. If budget is a concern, Cosequin + a separate fish oil covers a similar evidence base for less per month.
Before switching products, verify two things. First, are you giving the correct loading dose? For a 60-pound dog, two tablets per day for 4–6 weeks is the standard loading protocol — one tablet per day will not achieve therapeutic glucosamine levels in that timeframe. Many owners under-dose during loading and conclude the product doesn’t work. Second, is the joint issue severe enough that a supplement isn’t the right primary tool? If loading doses were correct and no improvement is visible at 8–12 weeks, discuss prescription pain management and possibly imaging with your vet before investing in a different supplement. If Cosequin at proper dose truly shows nothing and your vet rules out more serious pathology, switching to a GLM-based formula like PetLab (or a green-lipped mussel powder from a quality supplier) is a reasonable next step — particularly given GLM’s emerging advantage in head-to-head trials.
Cosequin DS+MSM bought in a 250-count bottle from Costco or Walmart is where the math works for budget-constrained owners. For a medium-size dog at maintenance (one tablet daily), the monthly cost runs $4.50–$9. With the $10–$15 you save versus PetLab, you can add a quality fish oil supplement — Zesty Paws, Nordic Naturals, or a generic anchovies-based oil from Chewy — to bring omega-3 anti-inflammatory support into the protocol. That combination (Cosequin DS+MSM + quality fish oil) covers glucosamine, chondroitin, MSM, and marine omega-3s for less per month than PetLab’s subscription alone. This is the combination that most veterinary nutritionists would consider well-rounded within a realistic budget. You are missing GLM’s specific bioactive lipids, but you’re covering the most evidence-supported bases.
This is more important than it sounds. A supplement that isn’t reliably consumed does nothing. PetLab’s pork or salmon flavor soft chews are palatability-designed to be eaten willingly by most dogs as a treat — compliance is rarely an issue. Before switching brands, check whether Cosequin’s soft chew version (available at most retailers) solves the tablet problem while keeping the ingredient profile you know. It costs somewhat more per serving than Cosequin tablets but still comes in below PetLab on monthly cost for most dog sizes. If Cosequin soft chews also get refused, PetLab chews are genuinely a different palatability category and worth trying. If compliance is the barrier, solving it with PetLab costs more but reliably beats a theoretically superior supplement your dog spits out every morning.
The research on preventive supplementation in large breed puppies is less established than for adult dogs with existing joint disease. That said, large and giant breeds with genetic predispositions to hip dysplasia or elbow dysplasia — German Shepherds, Labs, Goldens, Rottweilers — are candidates for early joint support under veterinary guidance. For preventive use in young dogs, some veterinary nutritionists prefer starting with a quality fish oil (omega-3 support) rather than a full glucosamine-chondroitin-MSM loading protocol, which is designed for maintenance of existing cartilage rather than promotion of normal joint development. Discuss with your vet before starting any supplement in a puppy under one year, as growing bone and cartilage respond differently than adult tissue. Either brand can be used preventively with vet guidance — PetLab’s omega-3 content may make it a more natural fit for early support, while Cosequin’s lower cost enables long-term preventive use without significant budget strain.
This guide is for general informational purposes only and does not constitute veterinary medical advice. Neither PetLab Co. nor Nutramax Cosequin is a veterinary-prescribed medication, and neither is intended to diagnose, treat, cure, or prevent any disease. Ingredient information and pricing reflect publicly available product labeling and retail listings and may have changed since publication. The FDA regulates pet supplements as animal feed, not drugs — claims on labels have not been pre-approved for safety or efficacy. Clinical research cited reflects publicly available peer-reviewed publications in veterinary medicine; individual dog responses vary significantly. Always consult a licensed veterinarian before beginning, changing, or stopping a supplement protocol — particularly if your dog is on prescription medications, has a chronic health condition, or is showing signs of joint pain or lameness. This content is entirely original.